This site is intended for healthcare professionals
Latest drug news
  • Home
  • /
  • News
  • /
  • 2022
  • /
  • 1
  • /
  • Roche launches the cobas pulse system, an industry...
News

Roche launches the cobas pulse system, an industry first professional blood glucose management solution with mobile digital health capabilities to improve patient care.

Read time: 1 mins
Published:15th Jan 2022
Roche announced the launch of the cobas pulse system in select countries accepting the CE Mark. The cobas pulse system marks Roche Diagnostics’ newest generation of connected point of care solutions for professional blood glucose management.

As an industry first, the cobas pulse system combines the form factor of a high-performance blood glucose meter with simple usability and expanded digital capabilities similar to that of a smartphone.

Glucose is among the most important biomarkers to assess patient health and predict, diagnose and manage metabolic disorders. In particular, the management of blood glucose in patients is critical to preventing acute and chronic complications that may lead to increased morbidity, mortality and healthcare costs. Against the backdrop of a rising epidemic of diabetes and other non-communicable diseases, the need to regularly perform this critical intervention adds to an ever-growing list of responsibilities facing stretched healthcare systems and professionals.

The cobas pulse system is Roche’s newest generation of connected professional blood glucose management solution, building on its legacy with Accu-Chek Inform II. Designed with advanced safety and performance, simplicity, and enhanced digital power at its core, the cobas pulse system serves as a gateway to the future of digital health - improving workflows and changing healthcare in favor of cost efficiency and better patient care. The cobas pulse system is reliable, safe to use in all professional care settings (including intensive care) and with patients of all ages (including neonates). The cobas pulse system features outstanding performance that meets the criteria of one of the latest guidelines for glucose meters. It is free from interferences and features an easy-to-clean and robust design equipped for 12,000 cycles of cleaning and disinfection. The cobas pulse system’s portability and intuitive Android-based interface make using it as simple as a smartphone. Among several other innovations, the cobas pulse system features an illuminated glucose strip port for ease of use in poorly lit environments, wireless charging, an embedded camera for multiple uses, and secure RFID badging. Cobas infinity edge smart equips the cobas pulse system with Roche-selected digital health applications that enable a truly versatile range of operations for patient and workflow management.

Roche intends to seek CE, IVDR and FDA approvals for the system in other markets, through 2022.

Condition: Diabetes Types 1 & 2
Type: drug

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Related news and insights